Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.
Russell FM, Licciardi PV, Balloch A, Biaukula V, Tikoduadua L, Carapetis JR, Nelson J, Jenney AW, Waqatakirewa L, Colquhoun S, Cheung YB, Tang ML, Mulholland EK. Russell FM, et al. Among authors: tikoduadua l. Vaccine. 2010 Apr 19;28(18):3086-94. doi: 10.1016/j.vaccine.2010.02.065. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20199764 Free PMC article. Clinical Trial.
Chest X-ray-confirmed pneumonia in children in Fiji.
Magree HC, Russell FM, Sa'aga R, Greenwood P, Tikoduadua L, Pryor J, Waqatakirewa L, Carapetis JR, Mulholland EK. Magree HC, et al. Among authors: tikoduadua l. Bull World Health Organ. 2005 Jun;83(6):427-33. Epub 2005 Jun 17. Bull World Health Organ. 2005. PMID: 15976893 Free PMC article.
The burden of hospitalised rotavirus infections in Fiji.
Jenney A, Tikoduadua L, Buadromo E, Barnes G, Kirkwood CD, Boniface K, Bines J, Mulholland K, Russell F. Jenney A, et al. Among authors: tikoduadua l. Vaccine. 2009 Nov 20;27 Suppl 5:F108-11. doi: 10.1016/j.vaccine.2009.08.071. Vaccine. 2009. PMID: 19931707
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.
Russell FM, Carapetis JR, Balloch A, Licciardi PV, Jenney AW, Tikoduadua L, Waqatakirewa L, Pryor J, Nelson J, Byrnes GB, Cheung YB, Tang ML, Mulholland EK. Russell FM, et al. Among authors: tikoduadua l. Vaccine. 2010 Apr 26;28(19):3341-9. doi: 10.1016/j.vaccine.2010.02.087. Epub 2010 Mar 4. Vaccine. 2010. PMID: 20206670 Free PMC article. Clinical Trial.
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, Chandra R, Seduadua A, Oftadeh S, Cheung YB, Gilbert GL, Mulholland EK. Russell FM, et al. Among authors: tikoduadua l. Clin Vaccine Immunol. 2010 Dec;17(12):1970-6. doi: 10.1128/CVI.00117-10. Epub 2010 Oct 13. Clin Vaccine Immunol. 2010. PMID: 20943882 Free PMC article. Clinical Trial.
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
Russell FM, Carapetis JR, Burton RL, Lin J, Licciardi PV, Balloch A, Tikoduadua L, Waqatakirewa L, Cheung YB, Tang ML, Nahm MH, Mulholland EK. Russell FM, et al. Among authors: tikoduadua l. Vaccine. 2011 Jan 10;29(3):535-44. doi: 10.1016/j.vaccine.2010.10.046. Epub 2010 Oct 31. Vaccine. 2011. PMID: 21044669 Free PMC article. Clinical Trial.
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.
Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML. Russell FM, et al. Among authors: tikoduadua l. Vaccine. 2011 Jun 15;29(27):4499-506. doi: 10.1016/j.vaccine.2011.04.038. Epub 2011 May 1. Vaccine. 2011. PMID: 21539882 Free PMC article. Clinical Trial.
31 results